CLINICAL_TRIALS
trial_result
· 2010-12-03
Clinical Trial Update: Drug Interaction Study Between AZD3355 and Nexium [Phase 1]
Summary
The Phase 1 drug interaction study of AZD3355 with Nexium in gastroesophageal reflux disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Phase 1 | Status: COMPLETED